https://www.latimes.com/doctors-scientists Doctors & Scientists en-US Fri, 28 Aug 2026 00:51:16 GMT https://www.latimes.com/doctors-scientists/innovations/news/story/rgmbs-2026-uniting-global-leaders-in-medical-biotechnology-innovation Fourth edition of Saudi Arabia’s flagship summit aims to accelerate biomanufacturing, precision medicine, and $34.6 billion non-oil GDP targets under royal patronage. Fri, 28 Aug 2026 00:51:16 GMT https://www.latimes.com/doctors-scientists/innovations/news/story/rgmbs-2026-uniting-global-leaders-in-medical-biotechnology-innovation https://www.latimes.com/doctors-scientists/medicine/primary-care/story/coffee-intake-liver-fat-scarring A Cedars-Sinai analysis of 354,957 adults links coffee intake to less liver fat, lower scarring, and a 47 percent lower risk of liver cancer. Tue, 25 Aug 2026 13:09:00 GMT https://www.latimes.com/doctors-scientists/medicine/primary-care/story/coffee-intake-liver-fat-scarring https://www.latimes.com/doctors-scientists/medicine/primary-care/story/california-retail-pharmacy-immunization-staffing-law California mandates dedicated pharmacy staffing and expands technician vaccine roles, reshaping retail immunization workflows. Tue, 25 Aug 2026 01:00:00 GMT https://www.latimes.com/doctors-scientists/medicine/primary-care/story/california-retail-pharmacy-immunization-staffing-law https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/red-light-myopia-therapy-foveal-cone-loss High-resolution retinal imaging shows decreased foveal cone density in children receiving red-light myopia therapy for over one year. Mon, 24 Aug 2026 23:09:08 GMT https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/red-light-myopia-therapy-foveal-cone-loss https://www.latimes.com/doctors-scientists/innovations/news/story/fda-letter-formula-industry-botulism-outbreaks Two infant botulism outbreaks traced to the same milk supplier pushed the FDA to tell formula makers their ingredient checks are not enough. Thu, 20 Aug 2026 12:12:00 GMT https://www.latimes.com/doctors-scientists/innovations/news/story/fda-letter-formula-industry-botulism-outbreaks https://www.latimes.com/doctors-scientists/innovations/technology/story/2026-08-19/california-ab-1883-workplace-surveillance-bill-explained Assembly Bill 1883 would bar AI-powered tools from reading workers' neural data or emotional states, with penalties up to $500 per violation. Wed, 19 Aug 2026 23:11:47 GMT https://www.latimes.com/doctors-scientists/innovations/technology/story/2026-08-19/california-ab-1883-workplace-surveillance-bill-explained https://www.latimes.com/live-well/beauty/story/lip-lift-vs-lip-filler Discover why patients are abandoning filler for the surgical lip lift. Dr. Gary Linkov explains how this procedure restores natural facial harmony and shape. Tue, 18 Aug 2026 23:13:31 GMT https://www.latimes.com/live-well/beauty/story/lip-lift-vs-lip-filler https://www.latimes.com/doctors-scientists/innovations/advancements/story/science-of-peptides-retatrutide Explore clinical evidence for peptide therapy, from GLP-1s to retatrutide. Dr. Amir Kalantar breaks down the science, safety, and future of metabolic medicine. Tue, 18 Aug 2026 17:10:50 GMT https://www.latimes.com/doctors-scientists/innovations/advancements/story/science-of-peptides-retatrutide https://www.latimes.com/doctors-scientists/innovations/news/story/fda-advisory-panel-peptides-503a-list An FDA advisory committee recommended six peptides for compounding, despite career staff citing thin human trial data and safety risks. Wed, 12 Aug 2026 23:05:00 GMT https://www.latimes.com/doctors-scientists/innovations/news/story/fda-advisory-panel-peptides-503a-list https://www.latimes.com/doctors-scientists/medicine/cancer/story/psma-pet-primary-staging-treatment-prostate-cancer Upfront PSMA PET imaging detects hidden metastases in early prostate cancer, altering treatment plans in up to one-third of cases. Wed, 05 Aug 2026 23:56:16 GMT https://www.latimes.com/doctors-scientists/medicine/cancer/story/psma-pet-primary-staging-treatment-prostate-cancer https://www.latimes.com/doctors-scientists/medicine/cancer/story/capivasertib-prostate-cancer-treatment Clinicians report that early AKT inhibition side effects are manageable, allowing four out of five patients to maintain therapy. Fri, 17 Jul 2026 00:16:50 GMT https://www.latimes.com/doctors-scientists/medicine/cancer/story/capivasertib-prostate-cancer-treatment https://www.latimes.com/doctors-scientists/medicine/cancer/story/targeted-langerhans-cell-histiocytosis-treatments Clinical trials show targeted kinase inhibitors provide high response rates in children with refractory histiocytic disorders. Tue, 14 Jul 2026 23:28:19 GMT https://www.latimes.com/doctors-scientists/medicine/cancer/story/targeted-langerhans-cell-histiocytosis-treatments https://www.latimes.com/doctors-scientists/medicine/cancer/story/multi-selective-rason-inhibitors-combating-resistance-cancer Tri-complex active-state platforms address primary mutational resistance pathways in advanced malignancies. Sat, 04 Jul 2026 12:18:00 GMT https://www.latimes.com/doctors-scientists/medicine/cancer/story/multi-selective-rason-inhibitors-combating-resistance-cancer https://www.latimes.com/doctors-scientists/medicine/primary-care/story/ehr-alerts-behavioral-sedative-use-seniors A JAMA trial shows that sequential EHR prompts based on behavioral science increase medication deprescribing in older adults by 40% Wed, 12 Aug 2026 22:48:13 GMT https://www.latimes.com/doctors-scientists/medicine/primary-care/story/ehr-alerts-behavioral-sedative-use-seniors https://www.latimes.com/doctors-scientists/medicine/primary-care/story/brain-insulin-resistance-refractory-depression-outcomes Impaired glucose signaling in the brain contributes to depression. Clinical trials demonstrate that reversing insulin resistance improves mood. Tue, 11 Aug 2026 12:18:00 GMT https://www.latimes.com/doctors-scientists/medicine/primary-care/story/brain-insulin-resistance-refractory-depression-outcomes https://www.latimes.com/doctors-scientists/medicine/primary-care/story/atopic-dermatitis-long-term-maintenance Long-term clinical data reveal that continuous systemic biologic therapy provides durable skin clearance and itch relief for chronic eczema. Fri, 17 Jul 2026 12:17:00 GMT https://www.latimes.com/doctors-scientists/medicine/primary-care/story/atopic-dermatitis-long-term-maintenance https://www.latimes.com/doctors-scientists/medicine/primary-care/story/clinicians-mandate-ocular-uv-protection Public health initiatives target the gap between skin safety awareness and ocular protection to reduce age-related cataract rates. Thu, 09 Jul 2026 18:54:54 GMT https://www.latimes.com/doctors-scientists/medicine/primary-care/story/clinicians-mandate-ocular-uv-protection https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/fda-approval-abaloparatide-male-osteoporosis-care FDA approval of daily abaloparatide gives men at high risk of osteoporotic fracture a potent bone-building option to correct care disparities. Tue, 11 Aug 2026 00:17:57 GMT https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/fda-approval-abaloparatide-male-osteoporosis-care https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/btk-inhibitor-non-relapsing-secondary-progressive-ms Clinical data from the HERCULES trial show that tolebrutinib reduces six-month confirmed disability progression by 31% in non-relapsing disease. Thu, 30 Jul 2026 21:06:00 GMT https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/btk-inhibitor-non-relapsing-secondary-progressive-ms https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/mrna-vaccine-kinetic-profiles-plasma-biodistribution Recent blood surveillance studies trace intact lipid nanoparticles and match degradation rates across commercial vaccine platforms. Wed, 15 Jul 2026 11:28:00 GMT https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/mrna-vaccine-kinetic-profiles-plasma-biodistribution https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/subdural-hematoma-reductions-liquid-embolization-seniors A liquid embolic procedure reduces the need for repeated surgical drainage in elderly patients managing chronic subdural hematomas. Mon, 13 Jul 2026 23:21:00 GMT https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/subdural-hematoma-reductions-liquid-embolization-seniors https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/urinary-tract-infections-complications-risks-data-diagnostics Anatomical factors and device integration require modified diagnostic workflows to manage complicated urinary tract infections effectively. Mon, 13 Jul 2026 20:21:46 GMT https://www.latimes.com/doctors-scientists/medicine/specialized-care/story/urinary-tract-infections-complications-risks-data-diagnostics https://www.latimes.com/doctors-scientists/innovations/news/story/2026-08-12/ember-lifesciences-alfresa-japan-alliance Ember LifeSciences and Alfresa Corp partner to bring advanced pharmaceutical cold chain solutions to Japan. Learn more about this Series A alliance. Wed, 12 Aug 2026 11:00:00 GMT https://www.latimes.com/doctors-scientists/innovations/news/story/2026-08-12/ember-lifesciences-alfresa-japan-alliance